Alpha‐lipoic acid does not acutely affect resistance and conduit artery function or oxidative stress in healthy men
- 4 June 2004
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 58 (3) , 243-248
Abstract
Aims: Alpha‐lipoic acid (ALA) is a thiol compound with antioxidant properties used in the treatment of diabetic polyneuropathy. ALA may also improve arterial function, but there have been scant human trials examining this notion. This project aimed to investigate the effects of oral and intra‐arterial ALA on changes in systemic and regional haemodynamics, respectively.Methods: In study 1, 16 healthy older men aged 58 ± 7 years (mean ± SD) received 600 mg of ALA or placebo, on two occasions 1 week apart, in a randomized cross‐over design. Repeated measures of peripheral and central haemodynamics were then obtained for 90 min. Central blood pressure and indices of arterial stiffness [augmentation index (AIx) and estimated aortic pulse wave velocity] were recorded non‐invasively using pulse wave analysis. Blood samples obtained pre‐ and post‐treatments were analysed for erythrocyte antioxidant enzyme activity, plasma nitrite and malondialdehyde. In study 2 the effects of incremental cumulative doses (0.5, 1.0, 1.5 and 2.0 mg ml−1 min−1) of intra‐arterial ALA on forearm blood flow (FBF) were assessed in eight healthy subjects (aged 31 ± 5 years) by conventional venous occlusion plethysmography.Results: There were no significant changes on any of the central or peripheral haemodynamic measures after either oral or direct arterial administration of ALA. Plasma ALA was detected after oral supplementation (95% confidence intervals 463, 761 ng ml−1), but did not alter cellular or plasma measures of oxidative stress.Conclusions: Neither oral nor intra‐arterial ALA had any effect on regional and systemic haemodynamics or measures of oxidative stress in healthy men.Keywords
This publication has 31 references indexed in Scilit:
- Central Pulse Pressure and Mortality in End-Stage Renal DiseaseHypertension, 2002
- Prevention of Hypertension, Insulin Resistance, and Oxidative Stress by α-Lipoic AcidHypertension, 2002
- Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathyExperimental and Clinical Endocrinology & Diabetes, 2000
- Dietary α-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive ratsJournal Of Hypertension, 2000
- α-Lipoic Acid: A Metabolic Antioxidant Which Regulates NF-κB Signal Transduction and Protects Against Oxidative InjuryDrug Metabolism Reviews, 1998
- Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acidExperimental and Clinical Endocrinology & Diabetes, 1996
- Lipoic Acid Improves Nerve Blood Flow, Reduces Oxidative Stress, and Improves Distal Nerve Conduction in Experimental Diabetic NeuropathyDiabetes Care, 1995
- Alpha-lipoic acid as a biological antioxidantFree Radical Biology and Medicine, 1995
- Measuring Forearm Blood Flow and Interpreting the Responses to Drugs and MediatorsHypertension, 1995
- Aortic input impedance in normal man: relationship to pressure wave forms.Circulation, 1980